Preventice has announced it has received FDA clearance for a new remote monitoring system, according to a news release.
The BodyGuardian remote monitoring system was developed in collaboration with Mayo Clinic. It is designed to support remote monitoring for individuals with cardiac arrhythmias, and is intended to allow physicians to monitor biometrics outside of the clinical setting, according to the company. A body sensor attached to the patient's chest collects data, including the patient's ECG, heart rate, respiration rate and activity level. Patient data can then be transmitted to physicians via mobile phone technology.
"We are thrilled that the FDA has provided clearance for the BodyGuardian RMS enabling Preventice to bring to market a real-time, remote connection between physicians and patients," said Jon Otterstatter, co-founder, president and CEO of Preventice, in the release. "Our vision at Preventice has been to maximize this industry-leading collaboration into a solution that enables health care providers to extend and improve care for their patients, where they live."
The company anticipates commercial availability of the BodyGuardian system by the end of 2012.
Preventice is headquartered in Minneapolis.
Related Articles on FDA Clearances:
SinuSys Completes FDA Submission for Sinus Dilation System
Siemens Receives FDA Clearance for Digital Radiography System
OptiMedica Receives FDA Clearance for Corneal Incisions With Catalys System